Literature DB >> 25510408

Gender aspects of survival after surgical treatment for rectal cancer.

M-L Lydrup1, P Höglund.   

Abstract

AIM: Longer survival in women than men after rectal cancer surgery has been reported. Our hypothesis was that after correction for their longer life expectancy a survival benefit for women would still remain.
METHOD: We studied 2792 patients diagnosed with rectal cancer in the southern part of Sweden between 1996 and 2006. The following parameters were included in a prespecified multivariable Cox regression analysis: age at diagnosis, gender, preoperative radiotherapy, stage, year and type of surgery. In addition to overall survival, relative survival was calculated using the Hakulinen approach utilizing an age-, gender- and calendar year-matched Swedish control cohort.
RESULTS: Female patients were significantly older, received neoadjuvant treatment less often and were more often operated on by local excision. Overall survival was significantly longer in women. In the multivariable analysis of relative survival, controlling for neoadjuvant treatment, Dukes stage and year and type of surgery, no significant effect of gender [hazard ratio (HR) 1.10 for men, P = 0.114] was found, whereas an improved relative survival with increased age (HR 0.96 per year, P < 0.001) was seen. In contrast, using the same multivariable model with no correction for underlying mortality in the population, male gender (HR 1.38, P < 0.001) and greater age (HR 1.05 per year, P < 0.001) increased the risk of death.
CONCLUSION: The results show that after correction for the underlying longer survival in women and some known confounders, survival after surgical treatment for rectal cancer appears to be gender neutral. Colorectal Disease
© 2014 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Rectal cancer; gender difference; radiotherapy; relative survival; surgical treatment

Mesh:

Year:  2015        PMID: 25510408     DOI: 10.1111/codi.12871

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.

Authors:  Daniel Delitto; Thomas J George; Tyler J Loftus; Peihua Qiu; George J Chang; Carmen J Allegra; William A Hall; Steven J Hughes; Sanda A Tan; Christiana M Shaw; Atif Iqbal
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

2.  Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study.

Authors:  Manuela Limam; Katarina Luise Matthes; Giulia Pestoni; Eleftheria Michalopoulou; Leonhard Held; Silvia Dehler; Dimitri Korol; Sabine Rohrmann
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-04       Impact factor: 4.553

3.  Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity.

Authors:  Monika Kozłowska-Geller; Stanisław Głuszek; Piotr Lewitowicz
Journal:  Prz Gastroenterol       Date:  2021-03-31

4.  Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study.

Authors:  Jianan Chen; Haipeng Chen; Fuqiang Zhao; Zheng Wang; Qian Liu
Journal:  Transl Cancer Res       Date:  2022-01       Impact factor: 1.241

5.  Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer.

Authors:  Cristina Sarasqueta; Mª Victoria Zunzunegui; José María Enríquez Navascues; Arrate Querejeta; Carlos Placer; Amaia Perales; Nerea Gonzalez; Urko Aguirre; Marisa Baré; Antonio Escobar; José María Quintana
Journal:  BMC Cancer       Date:  2020-08-14       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.